Prescription drug · ANDA
Lurasidone HCL NDC 72189-598
Lurasidone hydrochloride 40 mg/1 · Tablet · Oral · Direct_rx
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72189-598-30 | 72189059830 | 30 TABLET in 1 BOTTLE (72189-598-30)Marketed from Dec 16, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lurasidone HCL
- Generic name (nonproprietary)
- lurasidone hcl
- Active ingredients
- Lurasidone hydrochloride — 40 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Direct_rxNDC labeler code 72189
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 208045
- Marketing start
- Listing expires
- Identifiers
- Product ID 72189-598_296811cf-cba9-16c2-e063-6294a90acfa6SPL ID 296811cf-cba9-16c2-e063-6294a90acfa6SPL set ID 296811cf-cba8-16c2-e063-6294a90acfa6RxCUI 1040031UNII O0P4I5851I
- Pharmacologic class
- Atypical Antipsychotic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472189059830followed by a unit qualifier and the quantityPackage 72189-0598-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Lurasidone hydrochloride tablets are indicated for: Treatment of adult and adolescent patients (13 to 17 years) with schizophrenia [see Clinical Studies (14.1)]. Monotherapy treatment of adult and pediatric patients (10 to 17 years) with major depressive episode associated with bipolar I disorder (bipolar depression) [see Clinical Studies (14.2)]. Adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar I disorder (bipolar depression) [see Clinical Studies (14.2)].
Excerpt only. Read the full label for complete information.
About NDC 72189-598
- What is NDC 72189-598?
- 72189-598 is the product NDC for Lurasidone HCL, Lurasidone hydrochloride 40 mg/1 tablet, listed with the FDA by Direct_rx. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Lurasidone HCL.
- What is the active ingredient?
- Lurasidone hydrochloride.
- Who is the labeler?
- Direct_rx, NDC labeler code 72189. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Lurasidone HCL?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Other NDCs under ANDA 208045
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lurasidone Hydrochloride | Lurasidone hydrochloride 20 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-953 |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 40 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-954 |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 60 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-955 |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 60 mg/1 | TabletOral | Coupler LLC | 67046-1654 |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 20 mg/1 | TabletOral | Proficient Rx LP | 82804-215 |